• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥合服务不足社区宫颈癌筛查的差距:分子癌症早检及未来技术的前景

Bridging the gap in cervical cancer screening for underserved communities: MCED and the promise of future technologies.

作者信息

Alshammari Aya Hasan, Ishii Hideshi, Hirotsu Takaaki, Hatakeyama Hideyuki, Morishita Masayo, di Luccio Eric

机构信息

Shonan Research and Development Center, Hirotsu Bio Science Inc., Tokyo, Japan.

Department of Medical Data Science, Center of Medical Innovation and Translational Research, Osaka University Graduate School of Medicine, Suita, Japan.

出版信息

Front Oncol. 2024 Jul 29;14:1407008. doi: 10.3389/fonc.2024.1407008. eCollection 2024.

DOI:10.3389/fonc.2024.1407008
PMID:39135996
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11317246/
Abstract

Cervical cancer screening is a critical public health measure, especially vital for underserved communities where disparities in access and outcomes are pronounced. Despite the life-saving potential of regular screening, numerous barriers-including geographical isolation, cultural and linguistic challenges, and socioeconomic factors-severely hinder accessibility for these populations. Multicancer early detection (MCED) tests emerge as a potentially effective intervention, offering a less invasive, more accessible approach that could transform how screenings are conducted. This paper explores the existing challenges in traditional cervical cancer screening methods, the potential of MCED tests to address these barriers, and the implications of these technologies for global health equity. Through a comprehensive review, we highlight the need for culturally sensitive, tailored interventions and the importance of effectively overcoming logistical and financial difficulties to implement MCED tests. Despite the promise shown by MCED tests, the paper acknowledges significant implementation challenges, including cost, logistical obstacles, and the need for cultural acceptance and validation studies. This study emphasizes the necessity for equitable MCED test implementation strategies, highlighting the potential of these innovative technologies to advance global health equity in cervical cancer prevention.

摘要

宫颈癌筛查是一项关键的公共卫生措施,对服务不足的社区尤为重要,在这些社区,获得筛查的机会和筛查结果存在明显差异。尽管定期筛查具有挽救生命的潜力,但包括地理隔离、文化和语言挑战以及社会经济因素在内的众多障碍严重阻碍了这些人群获得筛查的机会。多癌早期检测(MCED)测试成为一种潜在有效的干预措施,提供了一种侵入性较小、更容易获得的方法,可能会改变筛查的进行方式。本文探讨了传统宫颈癌筛查方法中存在的现有挑战、MCED测试解决这些障碍的潜力以及这些技术对全球卫生公平性的影响。通过全面综述,我们强调了需要采取具有文化敏感性的、量身定制的干预措施,以及有效克服实施MCED测试的后勤和资金困难的重要性。尽管MCED测试显示出前景,但本文承认实施过程中存在重大挑战,包括成本、后勤障碍以及文化接受度和验证研究的必要性。这项研究强调了公平实施MCED测试策略的必要性,突出了这些创新技术在推进宫颈癌预防方面全球卫生公平性的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b209/11317246/8fc536bc5e01/fonc-14-1407008-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b209/11317246/8fc536bc5e01/fonc-14-1407008-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b209/11317246/8fc536bc5e01/fonc-14-1407008-g001.jpg

相似文献

1
Bridging the gap in cervical cancer screening for underserved communities: MCED and the promise of future technologies.弥合服务不足社区宫颈癌筛查的差距:分子癌症早检及未来技术的前景
Front Oncol. 2024 Jul 29;14:1407008. doi: 10.3389/fonc.2024.1407008. eCollection 2024.
2
Perceptions of multi-cancer early detection tests among communities facing barriers to health care.面临医疗保健障碍的社区对多癌早期检测测试的认知。
Health Aff Sch. 2024 Aug 16;2(9):qxae102. doi: 10.1093/haschl/qxae102. eCollection 2024 Sep.
3
Perspectives of private payers on multicancer early-detection tests: informing research, implementation, and policy.私人支付方对多癌早期检测测试的看法:为研究、实施和政策提供信息
Health Aff Sch. 2023 Jun 20;1(1):qxad005. doi: 10.1093/haschl/qxad005. eCollection 2023 Jul.
4
An Exploratory Analysis of the Cost-Effectiveness of a Multi-cancer Early Detection Blood Test Compared with Standard of Care Screening in Ontario, Canada.加拿大安大略省多癌种早期检测血液检测与标准护理筛查的成本效益探索性分析。
Pharmacoeconomics. 2024 Apr;42(4):393-407. doi: 10.1007/s40273-023-01345-9. Epub 2023 Dec 27.
5
Integrating Multi-Cancer Early Detection (MCED) Tests with Standard Cancer Screening: System Dynamics Model Development and Feasibility Testing.将多癌早期检测(MCED)测试与标准癌症筛查相结合:系统动力学模型开发与可行性测试。
Pharmacoecon Open. 2025 Jan;9(1):147-160. doi: 10.1007/s41669-024-00533-3. Epub 2024 Oct 18.
6
Integrating Artificial Intelligence for Advancing Multiple-Cancer Early Detection via Serum Biomarkers: A Narrative Review.整合人工智能通过血清生物标志物推进多种癌症早期检测:一篇叙述性综述。
Cancers (Basel). 2024 Feb 21;16(5):862. doi: 10.3390/cancers16050862.
7
Integrating primary care, shared decision making, and community engagement to facilitate equitable access to multi-cancer early detection clinical trials.整合初级保健、共同决策和社区参与,以促进公平参与多癌早期检测临床试验。
Front Oncol. 2024 Feb 29;13:1307459. doi: 10.3389/fonc.2023.1307459. eCollection 2023.
8
The promise and challenges of multi-cancer early detection assays for reducing cancer disparities.多癌早期检测检测在减少癌症差异方面的前景与挑战。
Front Oncol. 2024 Mar 8;14:1305843. doi: 10.3389/fonc.2024.1305843. eCollection 2024.
9
Attitudes to multi-cancer early detection (MCED) blood tests for population-based screening: A qualitative study in Great Britain.基于人群的筛查中多癌种早期检测(MCED)血液检测的态度:英国的一项定性研究。
Soc Sci Med. 2024 Apr;347:116762. doi: 10.1016/j.socscimed.2024.116762. Epub 2024 Mar 12.
10
Primary Care Provider Receptivity to Multi-Cancer Early Detection Test Use in Cancer Screening.初级保健提供者对在癌症筛查中使用多癌早期检测测试的接受度。
J Pers Med. 2023 Nov 29;13(12):1673. doi: 10.3390/jpm13121673.

引用本文的文献

1
Advances and Challenges in Cervical Cancer: From Molecular Mechanisms and Global Epidemiology to Innovative Therapies and Prevention Strategies.宫颈癌的进展与挑战:从分子机制、全球流行病学到创新疗法与预防策略
Cancer Control. 2025 Jan-Dec;32:10732748251336415. doi: 10.1177/10732748251336415. Epub 2025 Apr 23.
2
Advancing Veterinary Oncology: Next-Generation Diagnostics for Early Cancer Detection and Clinical Implementation.推进兽医肿瘤学:用于早期癌症检测和临床应用的下一代诊断技术。
Animals (Basel). 2025 Jan 30;15(3):389. doi: 10.3390/ani15030389.

本文引用的文献

1
Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population.普通人群中女性宫颈筛查、分流和治疗策略的获益、危害和成本效益。
Nat Med. 2023 Dec;29(12):3050-3058. doi: 10.1038/s41591-023-02600-4. Epub 2023 Dec 12.
2
Social Norms in Cervical Cancer Screening.宫颈癌筛查中的社会规范
Psychol Rep. 2023 Dec 4:332941231219943. doi: 10.1177/00332941231219943.
3
Barriers to cervical cancer screening faced by immigrant Muslim women: a systematic scoping review.移民穆斯林妇女在宫颈癌筛查上面临的障碍:系统范围综述。
BMC Public Health. 2023 Nov 30;23(1):2375. doi: 10.1186/s12889-023-17309-9.
4
Up-to-Date Breast, Cervical, and Colorectal Cancer Screening Test Use in the United States, 2021.2021 年美国最新的乳腺癌、宫颈癌和结直肠癌筛查检测应用情况。
Prev Chronic Dis. 2023 Oct 26;20:E94. doi: 10.5888/pcd20.230071.
5
Assessing Disparities in Cervical Cancer Screening with Pap Test by Disability Types.评估基于残疾类型的巴氏涂片宫颈癌筛查差异。
J Cancer Educ. 2024 Feb;39(1):39-49. doi: 10.1007/s13187-023-02373-x. Epub 2023 Oct 2.
6
Low-Cost Interventions to Improve Cervical Cancer Screening: An Integrative Review.低成本干预措施以改善宫颈癌筛查:综合评价。
Oncol Nurs Forum. 2022 Dec 16;50(1):59-78. doi: 10.1188/23.ONF.59-78.
7
Piloting a Community Education Skin Cancer Program Coordinated by Medical Students.试行一项由医学生协调开展的社区皮肤癌教育项目。
JMIR Dermatol. 2022 Aug 11;5(3):e36793. doi: 10.2196/36793.
8
The inclusion of diagnostics in national health insurance schemes in Cambodia, India, Indonesia, Nepal, Pakistan, Philippines and Viet Nam.柬埔寨、印度、印度尼西亚、尼泊尔、巴基斯坦、菲律宾和越南的国家健康保险计划中纳入诊断检测。
BMJ Glob Health. 2023 Jul;8(7). doi: 10.1136/bmjgh-2023-012512.
9
Healthcare Professionals' Specialists' Perception of Telemedicine in Romania-A Quantitative Study of Beliefs, Practices, and Expectations.医疗保健专业人员对罗马尼亚远程医疗的看法——一项关于信念、实践和期望的定量研究。
Healthcare (Basel). 2023 May 25;11(11):1552. doi: 10.3390/healthcare11111552.
10
Carcinogenesis and management of human papillomavirus-associated cervical cancer.人乳头瘤病毒相关宫颈癌的致癌作用与管理。
Int J Clin Oncol. 2023 Aug;28(8):965-974. doi: 10.1007/s10147-023-02337-7. Epub 2023 Jun 9.